Cytarabine/Fludarabine/Oxaliplatin/Rituximab Regimen

Preferred Label : Cytarabine/Fludarabine/Oxaliplatin/Rituximab Regimen;

NCIt synonyms : Cytarabine-Fludarabine-Oxaliplatin-Rituximab; Cytarabine/Fludarabine/Oxaliplatin/Rituxan; Oxaliplatin/Fludarabine/Cytarabine/Rituximab; Cytarabine/Fludarabine/Oxaliplatin/Rituximab;

NCIt related terms : OFAR (rituximab-arrx); OFAR (rituximab-pvvr); OFAR (rituximab-rite); OFAR (rituximab-rixi); OFAR (rituximab-abbs); OFAR (rituximab-rixa); OFAR; OFAR (rituximab-blit);

NCIt definition : A regimen consisting of cytarabine, fludarabine, oxaliplatin and rituximab that may be used in the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).;

NCI Metathesaurus CUI : CL1926312;

Codes from synonyms : 128377; 127906; 128691; 128220; 127749; 128063; 12620; 128534;

Details

Origin ID

C204007;

UMLS CUI

C5907834;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cytarabine [NCIt concept]
- Fludarabine Phosphate [NCIt concept]
- Oxaliplatin [NCIt concept]
- Rituximab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients